PFDN1

PFDN1 is one of six subunits of the heterohexameric prefoldin co-chaperone complex, where the distal tip of the PFDN1-containing tentacle forms binary complexes with nascent actin and tubulin for delivery into the folding pathway, with overlapping subunit-tip sets distinguishing actin from alpha- and beta-tubulin binding (PMID:14634002). Consistent with this cytoskeletal role, loss of PFDN1 reduces tubulin levels and microtubule growth and places it genetically upstream of CCT and tubulin folding (PMID:18062952), and Pfdn1-null mice show cytoskeleton-dependent defects including ciliary dyskinesia, neuronal loss, and blocked B and T lymphocyte maturation with impaired antigen-receptor capping (PMID:18566413). Subunit stoichiometry is enforced by the ubiquitin-proteasome system, which degrades unassembled monomers while complex-incorporated subunits are protected, so depletion of one subunit lowers the others (PMID:21478150). The intact complex acts as a clearance factor that suppresses pathological protein aggregation, blocking polyglutamine-expanded huntingtin at the small-oligomer stage (PMID:23720755) and co-localizing with polyubiquitinated aggregates to limit insoluble protein accumulation under proteasome and ER stress (PMID:23946485). Beyond chaperone function, PFDN1 is upregulated during TGF-β1-induced EMT and translocates to the nucleus, where it binds the cyclin A promoter to repress cyclin A and drive EMT and invasion in lung cancer, an effect rescued by cyclin A re-expression (PMID:27694898); at centrosomes its abundance is set by FILIP1L-dependent proteasomal degradation, and excess PFDN1 produces multinucleation and cytokinesis defects (PMID:34417201).

1. 2003 High

   Established the molecular basis of substrate capture by defining PFDN1 as a structural subunit whose tentacle tip mediates direct binding of actin and tubulin within the assembled prefoldin complex.

   Evidence In vitro reconstitution of recombinant subunits with engineered truncations and binary complex binding assays

   PMID:14634002

   Open questions at the time

   • Does not establish in vivo handoff kinetics to CCT/TRiC
   • Does not define PFDN1's contribution to native complex assembly in cells
2. 2003 High

   Placed PFDN1 functionally upstream of tubulin folding in vivo, showing its loss limits tubulin biogenesis and microtubule-dependent cellular processes.

   Evidence C. elegans pfd-1 null and RNAi with microtubule dynamics measurement and genetic epistasis to CCT and tubulin

   PMID:18062952

   Open questions at the time

   • Does not resolve whether actin folding contributes to the migration phenotype
   • Worm phenotypes not directly mapped to mammalian tissues
3. 2008 High

   Demonstrated the organismal consequences of PFDN1 loss, linking its cytoskeletal chaperone role to ciliary, neuronal, and lymphocyte-development phenotypes.

   Evidence Pfdn1 knockout mouse with flow-cytometric developmental staging and antigen-receptor capping assay

   PMID:18566413

   Open questions at the time

   • Does not separate cell-autonomous from systemic effects
   • Molecular link between tubulin/actin folding and capping not directly shown
4. 2011 Medium

   Explained how prefoldin stoichiometry is maintained, showing unassembled subunits are degraded by the UPS while complex incorporation confers protection.

   Evidence Reciprocal siRNA knockdown, MG132 treatment, and co-IP across subunit combinations

   PMID:21478150

   Open questions at the time

   • E3 ligase mediating monomer turnover not identified
   • Single lab; degradation signal on PFDN1 not mapped
5. 2014 Medium

   Extended prefoldin function beyond folding to active suppression of disease-associated aggregation, capturing huntingtin at the small-oligomer stage and limiting alpha-synuclein and ubiquitinated-protein accumulation.

   Evidence Single-molecule fluorescence in vitro, co-localization, and subunit knockdown with viability readouts

   PMID:23720755 PMID:23946485 PMID:24511594

   Open questions at the time

   • PFDN1-specific contribution inferred from disruption of other subunits
   • Mechanism of oligomer recognition not defined
6. 2016 High

   Revealed a non-canonical nuclear function in which PFDN1 acts as a direct transcriptional repressor of cyclin A to drive TGF-β1-induced EMT and invasion.

   Evidence ChIP at the cyclin A promoter, reciprocal gain/loss-of-function, cyclin A rescue, and xenograft

   PMID:27694898

   Open questions at the time

   • How nuclear translocation is triggered is unknown
   • Whether PFDN1 acts alone or within a transcriptional complex at the promoter is unresolved
7. 2021 High

   Identified FILIP1L as a centrosomal partner controlling PFDN1 localization and proteasomal turnover, linking PFDN1 dosage to faithful cytokinesis.

   Evidence Reciprocal Co-IP, centrosomal co-localization, time-lapse imaging, and FILIP1L knockout mouse/xenograft

   PMID:34417201 PMID:36860703

   Open questions at the time

   • The E3 ligase acting on centrosomal PFDN1 is not identified
   • Mechanistic link from excess PFDN1 to Wnt/β-catenin activation is inferred from FILIP1L loss
8. 2025 Medium

   Reinforced PFDN1 as a pro-tumorigenic factor in breast cancer, with silencing causing G2/M arrest, apoptosis, and downregulation of angiogenesis/EMT/hypoxia programs.

   Evidence siRNA knockdown with cell-cycle/apoptosis flow cytometry, migration/colony assays, and a 84-gene qRT-PCR array

   PMID:40063241

   Open questions at the time

   • No rescue or direct target validation beyond expression changes
   • Whether effects are chaperone- or transcription-dependent not resolved

• How PFDN1 partitions between its cytoplasmic chaperone, centrosomal, and nuclear transcriptional roles, and what signals govern these switches, remains unresolved.
• No structural or regulatory model for PFDN1 nuclear import
• The trigger redistributing PFDN1 among compartments is undefined